ROLE OF MRI IN DIAGNOSIS OF BLADDER CANCER FOR T-STAGING

Phương Thảo Nghiêm 1,, Thiện Vượng Nguyễn1
1 Pham Ngoc Thach University of Medicine

Main Article Content

Abstract

Objective: Describing imaging characteristics and assessing values of MRI in the diagnosis of bladder cancer at T-stage. Subjects and Methods: 40 patients with bladder cancer, undergo pelvic MRI, diagnosed, operated, and had pathology results from 01/06/2019 to 31/10/2022 at Binh Dan hospital. All MRI films were evaluated preoperatively and compared with histopathology postoperatively. Results: Among 40 patients being studied, the mean age was 61,25 ± 15,34; male predominance (67%). Histopathological results showed that transitional cell cancer accounted for the majority with 37 cases (92,5%), squamous cell cancer accounted for 7,5%. Out of 85 tumors, the most common tumor location was bilateral bladder 42%, mostly one tumor (70%). Featured images: mean size 18,18 ± 17,18; most frequently found polyp-shaped tumor 42,5%. There was a strong correlation between the shape and size of tumors and T staging (p<0.001). Most polypoid tumors were non-muscle invasive (76,5%). On T2 sequences, most tumors had intermediate signal (92,5%), low signal accounted for 7,5%. The value of sequences when in distinguishing tumors in T1 or lower and tumors in T2 or higher when using T2 sequences alone had the sensitivity, specificity and overall accuracy of 78,3%; 41,2%, 62,5%, accordingly. When combining T2 and DCE, these rates are 95,7%; 58,8%; 80%; when combining T2 and DWI these rates were 91,3%; 82,4%;87,5%. These rates were 95,7%; 88,2%; 92,5%, respectively, when combining 3 sequences T2, DCE and DWI. The area under the curve (AUC) for the VI-RADS scale in distinguishing muscle invasive of bladder was 0,948, with cut-off of 3 giving the highest sensitivity and specificity in diagnosis, 96,7% and 82,4% respectively.  Conclusion: MRI is an accurate method of bladder cancer for T-staging, helping clinicians having appropriate treatment plan for patients.

Article Details

References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
2. Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, et al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur Urol. 2020;77(1):101-9.
3. Lê Minh Hoàn, Trần Công Hoan. Giá trị cắt lớp vi tính đa dãy chẩn đoán ung thư bàng quang. Điện Quang Việt Nam. 2014.
4. Marchioni M, Primiceri G, Delli Pizzi A, Basilico R, Berardinelli F, Mincuzzi E, et al. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results from a Prospective Study. Clin Genitourin Cancer. 2020;18(5):409-15.
5. Nguyễn Quang Toàn. Nghiên cứu giá trị của cộng hưởng từ trong chẩn đoán giai đoạn T của ung thư bàng quang. Trường đại học Y Hà Nội. 2018.
6. Surveillance Research Program (SRP). Cancer Stat Facts: Bladder Cancer U.S: NIH - National Institutes of Health 2021 [Available from: https://seer.cancer.gov/statfacts/html/urinb.html.
7. Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, et al. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology. 2009;251(1):112-21.
8. Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2005;184(1):121-7.
9. Wang H, Luo C, Zhang F, Guan J, Li S, Yao H, et al. Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion. Radiology. 2019; 291(3):668-74.